Molecular Determinants of Chaperone Interactions on MHC-I for Folding and Antigen Repertoire Selection
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Evaluation of T-Cell and B-Cell Epitopes and Design of Multivalent Vaccines Against Htlv-1 Diseases
EVALUATION OF T-CELL AND B-CELL EPITOPES AND DESIGN OF MULTIVALENT VACCINES AGAINST HTLV-1 DISEASES DISSERTATION Presented in Partial Fulfillment of the Requirements for the Degree Doctor of Philosophy in the Graduate School of The Ohio State University By Roshni Sundaram, M.S. * * * * * The Ohio State University 2003 Dissertation Committee: Approved by Professor Pravin T.P. Kaumaya, Adviser Professor Christopher M. Walker Adviser Professor Neil R. Baker Department of Microbiology Professor Marshall V. Williams ABSTRACT Human T-cell lymphotropic virus type I (HTLV-1) is a C type retrovirus that is the causative agent of an aggressive T-cell malignancy, adult T-cell leukemia/lymphoma (ATLL). The virus is also implicated in a number of inflammatory disorders, the most prominent among them being HTLV-1 associated myelopathy or tropical spastic paraparesis (HAM/TSP). HTLV-1, like many viruses that cause chronic infection, has adapted to persist in the face of an active immune response in infected individuals. The viral transactivator Tax is the primary target of the cellular immune response and humoral responses are mainly directed against the envelope protein. Vaccination against HTLV-1 is a feasible option as there is very little genetic and antigenic variability. Vaccination regimes against chronic viruses must be aimed at augmenting the immune response to a level that is sufficient to clear the virus. This requires that the vaccine delivers a potent stimulus to the immune system that closely resembles natural infection to activate both the humoral arm and the cellular arm. It is also clear that multicomponent vaccines may be more beneficial in terms of increasing the breadth of the immune response as well as being applicable in an outbred population. -
NK Cell Memory to Cytomegalovirus: Implications for Vaccine Development
Review NK Cell Memory to Cytomegalovirus: Implications for Vaccine Development Calum Forrest 1 , Ariane Gomes 1 , Matthew Reeves 1,* and Victoria Male 2,* 1 Institute of Immunity & Transplantation, UCL, Royal Free Campus, London NW3 2PF, UK; [email protected] (C.F.); [email protected] (A.G.) 2 Department of Metabolism, Digestion and Reproduction, Imperial College London, Chelsea and Westminster Campus, London SW10 9NH, UK * Correspondence: [email protected] (M.R.); [email protected] (V.M.) Received: 24 June 2020; Accepted: 15 July 2020; Published: 20 July 2020 Abstract: Natural killer (NK) cells are innate lymphoid cells that recognize and eliminate virally-infected and cancerous cells. Members of the innate immune system are not usually considered to mediate immune memory, but over the past decade evidence has emerged that NK cells can do this in several contexts. Of these, the best understood and most widely accepted is the response to cytomegaloviruses, with strong evidence for memory to murine cytomegalovirus (MCMV) and several lines of evidence suggesting that the same is likely to be true of human cytomegalovirus (HCMV). The importance of NK cells in the context of HCMV infection is underscored by the armory of NK immune evasion genes encoded by HCMV aimed at subverting the NK cell immune response. As such, ongoing studies that have utilized HCMV to investigate NK cell diversity and function have proven instructive. Here, we discuss our current understanding of NK cell memory to viral infection with a focus on the response to cytomegaloviruses. We will then discuss the implications that this will have for the development of a vaccine against HCMV with particular emphasis on how a strategy that can harness the innate immune system and NK cells could be crucial for the development of a vaccine against this high-priority pathogen. -
Case of the Anti HIV-1 Antibody, B12
Spectrum of Somatic Hypermutations and Implication on Antibody Function: Case of the anti HIV-1 antibody, b12 Mesfin Mulugeta Gewe A dissertation submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy University of Washington 2015 Reading Committee: Roland Strong, Chair Nancy Maizels Jessica A. Hamerman Program Authorized to Offer Degree: Molecular and Cellular Biology i ii ©Copyright 2015 Mesfin Mulugeta Gewe iii University of Washington Abstract Spectrum of Somatic Hypermutations and Implication on Antibody Function: Case of the anti HIV-1 antibody, b12 Mesfin Mulugeta Gewe Chair of the Supervisory Committee: Roland Strong, Full Member Fred Hutchinson Cancer Research Center Sequence diversity, ability to evade immune detection and establishment of human immunodeficiency virus type 1 (HIV-1) latent reservoirs present a formidable challenge to the development of an HIV-1 vaccine. Structure based vaccine design stenciled on infection elicited broadly neutralizing antibodies (bNAbs) is a promising approach, in some measure to circumvent existing challenges. Understanding the antibody maturation process and importance of the high frequency mutations observed in anti-HIV-1 broadly neutralizing antibodies are imperative to the success of structure based vaccine immunogen design. Here we report a biochemical and structural characterization for the affinity maturation of infection elicited neutralizing antibodies IgG1 b12 (b12). We investigated the importance of affinity maturation and mutations accumulated therein in overall antibody function and their potential implications to vaccine development. Using a panel of point iv reversions, we examined relevance of individual amino acid mutations acquired during the affinity maturation process to deduce the role of somatic hypermutation in antibody function. -
Mapping B-Cell Epitopes for Nonspecific Lipid Transfer Proteins of Legumes Consumed in India and Identification of Critical Resi
foods Article Mapping B-Cell Epitopes for Nonspecific Lipid Transfer Proteins of Legumes Consumed in India and Identification of Critical Residues Responsible for IgE Binding Ankita Mishra 1,* and Ashok Kumar 1,2,3,4 1 Department of Biological Sciences and Bioengineering, Indian Institute of Technology Kanpur, Kanpur 208016, UP, India; [email protected] 2 Centre for Environmental Science and Engineering, Indian Institute of Technology Kanpur, Kanpur 208016, UP, India 3 Centre for Nanosciences, Indian Institute of Technology Kanpur, Kanpur 208016, UP, India 4 The Mehta Family Centre for Engineering in Medicine, Indian Institute of Technology Kanpur, Kanpur 208016, UP, India * Correspondence: [email protected] Abstract: Nonspecific lipid transfer proteins (nsLTPs) have been categorized as panallergens and display widespread occurrence across plant-kingdom. Present study, investigated B-cell epitopes for LTPs from chickpea, mung-bean, cowpea, pigeon-pea, and soybean via in silico methods. In-silico predicted regions were evaluated for epitope-conservancy and property-based peptide similarity search by different allergen databases. Additionally, the in-silico predicted regions were compared Citation: Mishra, A.; Kumar, A. with the experimentally validated epitopes of peach-LTP. Sequence-homology studies showed that Mapping B-Cell Epitopes for chickpea and mung-bean LTPs shared significant homology, i.e., >70% and >60%, respectively, with Nonspecific Lipid Transfer Proteins of other LTP allergens from lentil, garden-pea, peanut, etc. Phylogenetic-analysis also showed chickpea Legumes Consumed in India and and mung-bean LTPs to be closely related to allergenic LTPs from lentil and peanut, respectively. Identification of Critical Residues Responsible for IgE Binding. Foods Epitope-conservation analysis showed that two of the predicted B-cell epitopic regions in chickpea 2021, 10, 1269. -
Opportunities for Conformation-Selective Antibodies in Amyloid-Related Diseases
Antibodies 2015, 4, 170-196; doi:10.3390/antib4030170 OPEN ACCESS antibodies ISSN 2073-4468 www.mdpi.com/journal/antibodies Review Opportunities for Conformation-Selective Antibodies in Amyloid-Related Diseases Marta Westwood * and Alastair D. G. Lawson Structural Biology, UCB, 216 Bath Road, Slough, SL1 3WE UK; E-Mail: [email protected]. * Author to whom correspondence should be addressed; E-Mail: [email protected]; Tel.: +44-1-753-534-655 (ext.7749); Fax: +44-1-753-536-632. Academic Editor: Dimiter S. Dimitrov Received: 13 May 2015 / Accepted: 9 July 2015 / Published: 15 July 2015 Abstract: Assembly of misfolded proteins into fibrillar deposits is a common feature of many neurodegenerative diseases. Developing effective therapies to these complex, and not yet fully understood diseases is currently one of the greatest medical challenges facing society. Slow and initially asymptomatic onset of neurodegenerative disorders requires profound understanding of the processes occurring at early stages of the disease including identification and structural characterisation of initial toxic species underlying neurodegeneration. In this review, we chart the latest progress made towards understanding the multifactorial process leading to amyloid formation and highlight efforts made in the development of therapeutic antibodies for the treatment of amyloid-based disorders. The specificity and selectivity of conformational antibodies make them attractive research probes to differentiate between transient states preceding formation of mature fibrils and enable strategies for potential therapeutic intervention to be considered. Keywords: antibody; amyloids; conformation; prion; Alzheimer’s; Parkinson’s; fibrils, tau; Huntingtin; protein misfolding 1. Introduction Correct protein folding is crucial for maintaining healthy biological functions. -
Inhibition of Allergic Reactivity Through Targeting Fcεri-Bound Ige with Humanized Low-Affinity Antibodies
Inhibition of Allergic Reactivity through Targeting Fc εRI-Bound IgE with Humanized Low-Affinity Antibodies This information is current as Ke Zhang, Michael Elias, Hong Zhang, Jeffrey Liu, of September 27, 2021. Christopher Kepley, Yun Bai, Dean D. Metcalfe, Zachary Schiller, Yang Wang and Andrew Saxon J Immunol published online 21 October 2019 http://www.jimmunol.org/content/early/2019/10/19/jimmun ol.1900112 Downloaded from Why The JI? Submit online. http://www.jimmunol.org/ • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication *average by guest on September 27, 2021 Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2019 by The American Association of Immunologists, Inc. All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. Published October 21, 2019, doi:10.4049/jimmunol.1900112 The Journal of Immunology Inhibition of Allergic Reactivity through Targeting Fc«RI-Bound IgE with Humanized Low-Affinity Antibodies Ke Zhang,* Michael Elias,† Hong Zhang,* Jeffrey Liu,* Christopher Kepley,† Yun Bai,‡ Dean D. Metcalfe,‡ Zachary Schiller,x Yang Wang,x and Andrew Saxon* Options for effective prevention and treatment of epidemic allergic diseases remain limited, and particularly so for IgE-mediated 26 28 food allergies. -
The T Cell Repertoire Specific for the IE-1 Protein of Human Cytomegalovirus: Diversity, Function and Evasion
Dissertation zur Erlangung des Doktorgrades der Fakultät für Chemie und Pharmazie der Ludwig-Maximilians-Universität München The T cell repertoire specific for the IE-1 protein of human cytomegalovirus: diversity, function and evasion von Stefanie Maria Ameres aus Deggendorf, Deutschland 2012 Erklärung Diese Dissertation wurde im Sinne von §7 der Promotionsordnung vom 28. November 2011 von Herrn Prof. Dr. Wolfgang Hammerschmidt betreut und von Herrn Prof. Dr. Horst Domdey vor der Fakultät für Chemie und Pharmazie vertreten. Eidesstattliche Versicherung Diese Dissertation wurde eigenständig und ohne unerlaubte Hilfe erarbeitet. München, den 03.07.2012 Stefanie Ameres Dissertation eingereicht am 03.07.2012 1. Gutachter: Prof. Dr. Horst Domdey 2. Gutachter: Prof. Dr. Wolfgang Hammerschmidt Mündliche Prüfung am 28.01.2013 Teile dieser Arbeit werden/wurden wie folgt veröffentlicht: Ameres, S., J. Mautner, F. Schlott, M. Neuenhahn, D.H. Busch, B. Plachter, and A. Moosmann. Antigen Presentation to an Immunodominant Population of HLA-C-Restricted T Cells Resists Cytomegalovirus Immunoevasion. 2nd revision PLOS Pathogens Hesse, J., S. Ameres, K. Besold, S. Krauter, A. Moosmann, and B. Plachter. Suppression of CD8+ T-cell recognition in the immediate-early phase of human cytomegalovirus infection. Epub oct 2012. J. Gen. Virol. Teile dieser Arbeit wurden im Rahmen der Dissertation wie folgt präsentiert: May 3rd–4th, 2012 DFG SFB-TR36 Symposium "Adoptive T Cell Therapy" Berlin, Germany Talk: "CD8+ T cells overcome HCMV immunoevasion dependent on their HLA restriction" Dec. 5th–7th, 2011 DFG SFB-TR36 Retreat "Principles and Applications of Wildbad Kreuth, Adoptive T Cell therapy" Germany Talk: "CD8+ T cells defeat HCMV immunoevasins dependent on MHC restriction" May 14th–17th, 2011 13th International CMV/Betaherpesvirus Workshop Nürnberg, Germany Poster 1: "Preferential T cell control of HCMV infection through HLA-C" Poster 2: "HCMV IE-1 is recognized by a diverse repertoire of CD4+ Tcells" Oct. -
Ige – the Main Player of Food Allergy
DDMOD-431; No of Pages 8 Vol. xxx, No. xx 2016 Drug Discovery Today: Disease Models Editors-in-Chief Jan Tornell – AstraZeneca, Sweden DRUG DISCOVERY Andrew McCulloch – University of California, SanDiego, USA TODAY DISEASE MODELS IgE – the main player of food allergy 1 2,3 2 Henrike C.H. Broekman , Thomas Eiwegger , Julia Upton , 4, Katrine L. Bøgh * 1 Department of Dermatology/Allergology, University Medical Centre Utrecht (UMCU), Utrecht, The Netherlands 2 Division of Immunology and Allergy, Food Allergy and Anaphylaxis Program, The Department of Paediatrics, Hospital for Sick Children, Toronto, Canada 3 Research Institute, Physiology and Experimental Medicine, The University of Toronto, Toronto, Canada 4 National Food Institute, Technical University of Denmark, Søborg, Denmark Food allergy is a growing problem worldwide, presently Section editor: affecting 2–4% of adults and 5–8% of young children. IgE Michelle Epstein – Medical University of Vienna, is a key player in food allergy. Consequently huge Department of Dermatology, DIAID, Experimental Allergy, Waehringer Guertel 18-20, Room 4P9.02, A1090, efforts have been made to develop tests to detect Vienna, Austria. either the presence of IgE molecules, their allergen binding sites or their functionality, in order to provide allergen ingestion [1], and involve one or more of the follow- information regarding the patient’s food allergy. The ing systems; the skin (pruritus, urticaria, or angioedema), the ultimate goal is to develop tools that are capable of gastro-intestinal tract (diarrhea, vomiting, contractions, in- creased bowel movement), the respiratory tract (asthma at- discriminating between asymptomatic sensitization tack, hoarseness, stridor/laryngeal angioedema) or the and a clinically relevant food allergy, and between cardiovascular system (dizziness, drop in blood pressure, loss different allergic phenotypes in an accurate and trust- of consciousness) [2,3]. -
Structural Basis of Mouse Cytomegalovirus M152/Gp40 Interaction with Rae1γ Reveals a Paradigm for MHC/MHC Interaction in Immune
Structural basis of mouse cytomegalovirus m152/gp40 PNAS PLUS interaction with RAE1γ reveals a paradigm for MHC/MHC interaction in immune evasion Rui Wanga, Kannan Natarajana, Maria Jamela R. Revillezaa, Lisa F. Boyda, Li Zhia,1, Huaying Zhaob, Howard Robinsonc, and David H. Marguliesa,2 aMolecular Biology Section, Laboratory of Immunology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892; bDynamics of Macromolecular Assembly Section, Laboratory of Cellular Imaging and Macromolecular Biophysics, National Institute of Biomolecular Imaging and Bioengineering, National Institutes of Health, Bethesda, MD 20892; and cNational Synchrotron Light Source, Brookhaven National Laboratories, Upton, NY 11973 Edited by K. Christopher Garcia, Stanford University, Stanford, CA, and approved October 24, 2012 (received for review August 17, 2012) Natural killer (NK) cells are activated by engagement of the NKG2D NKG2D ligands, we examined the binding of the MCMV m152 receptor with ligands on target cells stressed by infection or glycoprotein to its RAE1 ligands. Our previous studies investigated tumorigenesis. Several human and rodent cytomegalovirus (CMV) the quantitative interaction of m152 with different RAE1 isoforms immunoevasins down-regulate surface expression of NKG2D (21). Here we report the X-ray structure of the complex of m152 ligands. The mouse CMV MHC class I (MHC-I)–like m152/gp40 glyco- with RAE1γ, the confirmation of the intermolecular contacts protein down-regulates retinoic acid early inducible-1 (RAE1) observed in the crystal structure by site-directed mutagenesis and NKG2D ligands as well as host MHC-I. Here we describe the crystal in vitro binding assays, a comparison of the binding of m152 to structure of an m152/RAE1γ complex and confirm the intermolec- RAE1 and of NKG2D to RAE1, and the functional effects of ular contacts by mutagenesis. -
Characterization of Conformational B-Cell
PEPTIDE-BASED B-CELL EPITOPE VACCINES TARGETING HER-2/NEU DISSERTATION Presented in Partial Fulfillment of the Requirements for the Degree of Doctor of Philosophy in the Graduate School of The Ohio State University By Joan T. Garrett, B.S./B.A. ***** The Ohio State University 2007 Dissertation Committee: Approved by Professor Pravin Kaumaya, Advisor ___________________________ Advisor Professor Dehua Pei, Advisor Professor Ross Dalbey ___________________________ Advisor Professor Thomas Magliery Graduate Program in Chemistry ABSTRACT HER-2/neu (ErbB2), a member of the epidermal growth factor family of receptors (EGFR) is overexpressed in a significant fraction of breast cancers. It is an attractive target for receptor-directed antitumor therapy using monoclonal antibodies. Trastuzumab and pertuzumab are growth-inhibitory humanized antibodies targeting the oncogenic protein HER-2/neu. Although passive immunotherapy with trastuzumab is approved for treatment of breast cancer, a number of concerns exist with passive immunotherapy. Treatment is expensive, and has a limited duration of action, necessitating repeated administrations of the monoclonal antibody. Active immunotherapy with conformational B-cell epitopes affords the possibility of generating an enduring immune response, eliciting protein-reactive high-affinity anti-peptide antibodies. The three-dimensional structure of human HER-2 in complex with trastuzumab reveals that the antigen binding region of HER-2 spans residues 563-626 that comprises an extensive disulfide bonding pattern. In order to minimally dissect the interacting binding region of HER-2, we have designed four synthetic peptides with different levels of conformational flexibility. Chimeric peptides incorporating the measles virus fusion ‘promiscuous’ T cell epitope via a four-residue linker sequence were synthesized, purified, and characterized. -
The Murine Cytomegalovirus Immunoevasin Gp40 Binds MHC
© 2016. Published by The Company of Biologists Ltd | Journal of Cell Science (2016) 129, 219-227 doi:10.1242/jcs.175620 RESEARCH ARTICLE The murine cytomegalovirus immunoevasin gp40 binds MHC class I molecules to retain them in the early secretory pathway Linda Janßen1, Venkat Raman Ramnarayan1, Mohamed Aboelmagd1, Maro Iliopoulou1, Zeynep Hein1, Irina Majoul2, Susanne Fritzsche1, Anne Halenius3 and Sebastian Springer1,* ABSTRACT ERGIC or cis-Golgi, and we demonstrate that a sequence in the In the presence of the murine cytomegalovirus (mCMV) gp40 (m152) linker between the folded lumenal domain of gp40 and the protein, murine major histocompatibility complex (MHC) class I transmembrane sequence is required for this retention. molecules do not reach the cell surface but are retained in an early compartment of the secretory pathway. We find that gp40 does not RESULTS impair the folding or high-affinity peptide binding of the class I Gp40 retains MHC class I in the early secretory pathway molecules but binds to them, leading to their retention in the To assess the effect of gp40 on murine class I molecules, we m152 endoplasmic reticulum (ER), the ER-Golgi intermediate compartment expressed in K41 cells (murine fibroblasts) by lentiviral (ERGIC) and the cis-Golgi, most likely by retrieval from the cis-Golgi to transduction. The surface levels of the endogenous class I allotypes b b b b the ER. We identify a sequence in gp40 that is required for both its own H-2D (D ) and H-2K (K ) were reduced to background levels in retention in the early secretory pathway and for that of class I most cells, as observed by flow cytometry with the allotype-specific β b molecules. -
Epstein-Barr Virus May Contribute to Central Nervous System Involvement in HIV-Positive Individuals
bioRxiv preprint doi: https://doi.org/10.1101/341354; this version posted June 7, 2018. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. 1 Epstein-Barr Virus May Contribute to Central Nervous System Involvement in HIV-positive 2 Individuals 3 Lupia T1#*, Milia MG2, Atzori C3, Audagnotto S1, Imperiale D3, Mighetto L4, Pirriatore V1, Gregori G2, 4 Lipani F1, Ghisetti V2, Bonora S1, Di Perri G1, Calcagno A1. 5 1 Unit of Infectious Diseases, Department of Medical Sciences, University of Torino, Torino, Italy 6 2 Laboratory of Virology and Molecular Biology, Ospedale Amedeo di Savoia, ASL “Città di Torino”, 7 Torino, Italy 8 3 Unit of Neurology, Ospedale Maria Vittoria, ASL “Città di Torino”, Torino, Italy 9 4 Laboratory of Immunology, Ospedale Maria Vittoria, ASL “Città di Torino”, Torino, Italy. 10 11 Running Head: EBV and HIV in the CSF 12 13 14 #Address correspondence to Tommaso Lupia, [email protected] 15 *Present address: Tommaso Lupia, Unit of Infectious Diseases, Department of Medical Sciences, 16 University of Torino, Amedeo di Savoia Hospital, C.so Svizzera 164, 10149 Torino, Italy 17 18 19 20 Type of article: Original article 21 22 Key words: EBV; HIV; central nervous system; blood brain barrier; trafficking; biomarkers; S-100 23 beta. 24 25 Word count: Total 2097 (Abstract 250) 26 27 Figures: 3 28 29 Tables: 2 30 31 32 Conflicts of Interest and Source of Funding: AC has received honoraria from Abbvie, BMS, Gilead, 33 Janssen-Cilag, MSD, Viiv and he is currently receiving research grants from BMS, Gilead and Viiv.